Search 

Founded in 2002, GenScript is committed to making humans and environment healthier through innovation. With its over 3,000 employees globally and R&D centers in the U.S., China and Europe, GenScript has become a global leader in providing research, biologics development services, synthetic biology products as well as a world class leader in cell therapy to help patients conquer serious diseases

I manage 2 USD funds focus on cross boarder investment strategy, and I sit on the board of Twist Bioscience( NASDAQ: TWST)

New drug development

gloria

Medical Machine investment

Guangdong Fengle Group Co., Ltd. (hereinafter referred to as “Fengle Group”), established in 2004, is a diversified and comprehensive industrial group corporation integrated of industry, commerce and Finance.
Fengle Group focuses on energy, new energy, energy conservation and environmental protection, industrial investment and holding, and supply chain finance, optimizing strategic layout and business structure.
Fengle group joined new fields of urban renewal, rural revitalization, medical technology, modern agriculture and animal husbandry etc. while expanding its traditional businesses.
Fengle Group headquartered in Zengcheng district, Guangzhou, then set up five management headquarters in South China, North China, East China, Southwest and Northwest China, achieving nationalization of region and products.
Fengle Group operates in more than 10 countries and regions and creates an annual output value of more than 10 billion yuan.
Guangzhou Fengle Medical Technology Co., Ltd. was founded by the parent company Guangdong Fengle Group Co.,Ltd. The face mask plant of Fengle Medical covers an area of 15,000 square meters, equipped with automatic mask production equipment, automatic packaging equipment, inspection and testing equipment.
Fengle Medical has been established with fine industry, adhering to the philosophy of value discovery, innovation and enlightenment, dedication and altruism, people-oriented, harmony and honesty, cooperation and sharing, innovation and win-win. It provides customers with a full range of quality and value-added services to achieve customer satisfaction, company satisfaction, social satisfaction. Due to rigorous, scientific, efficient and reasonable management system, the company's operation is more standardized, that become a leader in the local industry, developing steadily, rapidly and efficiently.
At present, the company's main products are: Disposable protective masks, disposable children's masks, disposable medical masks, medical surgical masks, KN95 protective masks etc. All the products have obtained the full performance Inspection and Test Report, in line with the relevant national standards and requirements. The company has obtained the ISO 13485 quality system certification, obtained the European Union CE certification, the United States FDA listing for the record, and listed in the "China Chamber of Commerce for Import and Export of Medicines and Health Products Double White List".
Health care is a sunrise industry forever. Fengle Group will take Fengle Medical Technology Co., Ltd as the starting point to build a comprehensive and integrated medical health industry base in the region by connecting with Zhongguancun and the provincial venture capital medical devices, classification diagnosis and treatment, remote diagnosis, health, research and development, and venture capital big data resources.

indUnited Statestry

Guoqian Medical Technology (Suzhou) Co., Ltd. was registered and established in Suzhou High-tech Zone in 2017.

Guoqian Medical has two business platforms: Guoqian Venture Capital and Guoqian Medical Technology Innovation Research Institute.

Guoqian Venture Capital is a professional and market-oriented venture capital institution that focuses on equity investment in early innovation and entrepreneurship projects in the fields of medical devices, in vitro diagnostic reagents and biotechnology. Focusing on high-end scientific and technological talents with Chinese major talent engineering experts as the core, they seek high-quality investment targets during the transformation of scientific and technological achievements, the introduction of technological projects, the evaluation of innovative and entrepreneurial projects, and the landing of innovative and entrepreneurial projects.

Guoqian Medical Technology Innovation Research Institute is committed to cultivating cutting-edge technologies and projects in the domestic medical device industry, and providing it with multi-faceted technologies, policies, talents, industrialization and markets through direct investment, entrepreneurial services, and scientific and technological achievement transformation services. Integration of services and resources to create an innovative platform for national technological innovation and industrial integration and empowerment. At the same time, it has also become an enabling platform for post-investment enterprises of Guoqian Fund. By creating industrial clusters and industrial ecology, it will provide post-investment management, post-investment services, and post-investment empowerment to post-investment enterprises.

Based on the business philosophy of “achieving the dreams of others”, Guoqian Medical uses market-oriented and specialized equity investment funds to create industrial agglomeration and industrial ecology; it empowers post-investment enterprises by creating industrial agglomeration and industrial ecology. The two platforms complement each other, and strive to build a medical device industry cluster and ecosystem in Suzhou High-tech Zone in 10 years, becoming one of the main promoters of the domestic medical device industry.

Leading Investment and security company in China